Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039220450> ?p ?o ?g. }
- W2039220450 endingPage "2720" @default.
- W2039220450 startingPage "2711" @default.
- W2039220450 abstract "Abstract Emodin (1,3,8‐trihydroxy‐6‐methylanthraquinone), an active component in the root and rhizome of Rheum palmatum , is a tyrosine kinase inhibitor with a number of biological activities, including antitumor effects. Here, we examine the effects of emodin on vascular endothelial growth factor (VEGF)‐A‐induced angiogenesis, both in vitro and in vivo . In vitro , emodin dose‐dependently inhibits proliferation, migration into the denuded area, invasion through a layer of Matrigel and tube formation of human umbilical vein endothelial cells (HUVECs) stimulated with VEGF‐A. Emodin also inhibits basic fibroblast growth factor‐induced proliferation and migration of HUVECs and VEGF‐A‐induced tube formation of human dermal microvascular endothelial cells. Specifically, emodin induces the cell cycle arrest of HUVECs in the G 0 /G 1 phase by suppressing cyclin D1 and E expression and retinoblastoma protein phosphorylation, and suppresses Matrigel invasion by inhibiting the basal secretion of matrix metalloproteinase‐2 and VEGF‐A‐stimulated urokinase plasminogen activator receptor expression. Additionally, emodin effectively inhibits phosphorylation of VEGF‐A receptor‐2 (KDR/Flk‐1) and downstream effector molecules, including focal adhesion kinase, extracellular signal‐regulated kinase 1/2, p38 mitogen‐activated protein kinase, Akt and endothelial nitric oxide synthase. In vivo , emodin strongly suppresses neovessel formation in the chorioallantoic membrane of chick and VEGF‐A‐induced angiogenesis of the Matrigel plug in mice. Our data collectively demonstrate that emodin effectively inhibits VEGF‐A‐induced angiogenesis in vitro and in vivo . Moreover, inhibition of phosphorylation of KDR/Flk‐1 and downstream effector molecules is a possible underlying mechanism of the anti‐angiogenic activity of emodin. Based on these data, we propose that an interaction of emodin with KDR/Flk‐1 may be involved in the inhibitory function of emodin toward VEGF‐A‐induced angiogenesis in vitro and responsible for its potent anti‐angiogenic in vivo . © 2006 Wiley‐Liss, Inc." @default.
- W2039220450 created "2016-06-24" @default.
- W2039220450 creator A5006019721 @default.
- W2039220450 creator A5008871978 @default.
- W2039220450 creator A5013293905 @default.
- W2039220450 creator A5018301481 @default.
- W2039220450 creator A5030635526 @default.
- W2039220450 creator A5036650797 @default.
- W2039220450 creator A5045714739 @default.
- W2039220450 creator A5050841050 @default.
- W2039220450 creator A5051867302 @default.
- W2039220450 creator A5058516635 @default.
- W2039220450 creator A5082018557 @default.
- W2039220450 creator A5082673485 @default.
- W2039220450 creator A5091068973 @default.
- W2039220450 date "2006-03-14" @default.
- W2039220450 modified "2023-10-15" @default.
- W2039220450 title "Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation" @default.
- W2039220450 cites W1607892649 @default.
- W2039220450 cites W1678800844 @default.
- W2039220450 cites W1679229092 @default.
- W2039220450 cites W1949259756 @default.
- W2039220450 cites W1964424550 @default.
- W2039220450 cites W1966931906 @default.
- W2039220450 cites W1978139448 @default.
- W2039220450 cites W1980839209 @default.
- W2039220450 cites W1980969801 @default.
- W2039220450 cites W1981428626 @default.
- W2039220450 cites W1982859282 @default.
- W2039220450 cites W1984584032 @default.
- W2039220450 cites W1985712533 @default.
- W2039220450 cites W1985804036 @default.
- W2039220450 cites W1986669455 @default.
- W2039220450 cites W1988912859 @default.
- W2039220450 cites W1994360534 @default.
- W2039220450 cites W1995088117 @default.
- W2039220450 cites W2000000541 @default.
- W2039220450 cites W2000292756 @default.
- W2039220450 cites W2001102844 @default.
- W2039220450 cites W2010911717 @default.
- W2039220450 cites W2016011980 @default.
- W2039220450 cites W2016642619 @default.
- W2039220450 cites W2018512891 @default.
- W2039220450 cites W2026803058 @default.
- W2039220450 cites W2027329004 @default.
- W2039220450 cites W2030025004 @default.
- W2039220450 cites W2040123299 @default.
- W2039220450 cites W2041034845 @default.
- W2039220450 cites W2051347744 @default.
- W2039220450 cites W2059992425 @default.
- W2039220450 cites W2084583180 @default.
- W2039220450 cites W2093213790 @default.
- W2039220450 cites W2102140960 @default.
- W2039220450 cites W2131420129 @default.
- W2039220450 cites W2140614131 @default.
- W2039220450 cites W2146519773 @default.
- W2039220450 cites W2155103945 @default.
- W2039220450 cites W2170723552 @default.
- W2039220450 cites W2332221663 @default.
- W2039220450 cites W2414769601 @default.
- W2039220450 cites W3143360378 @default.
- W2039220450 cites W56534538 @default.
- W2039220450 doi "https://doi.org/10.1002/ijc.21641" @default.
- W2039220450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16388516" @default.
- W2039220450 hasPublicationYear "2006" @default.
- W2039220450 type Work @default.
- W2039220450 sameAs 2039220450 @default.
- W2039220450 citedByCount "92" @default.
- W2039220450 countsByYear W20392204502012 @default.
- W2039220450 countsByYear W20392204502013 @default.
- W2039220450 countsByYear W20392204502014 @default.
- W2039220450 countsByYear W20392204502015 @default.
- W2039220450 countsByYear W20392204502016 @default.
- W2039220450 countsByYear W20392204502017 @default.
- W2039220450 countsByYear W20392204502018 @default.
- W2039220450 countsByYear W20392204502019 @default.
- W2039220450 countsByYear W20392204502020 @default.
- W2039220450 countsByYear W20392204502021 @default.
- W2039220450 countsByYear W20392204502022 @default.
- W2039220450 crossrefType "journal-article" @default.
- W2039220450 hasAuthorship W2039220450A5006019721 @default.
- W2039220450 hasAuthorship W2039220450A5008871978 @default.
- W2039220450 hasAuthorship W2039220450A5013293905 @default.
- W2039220450 hasAuthorship W2039220450A5018301481 @default.
- W2039220450 hasAuthorship W2039220450A5030635526 @default.
- W2039220450 hasAuthorship W2039220450A5036650797 @default.
- W2039220450 hasAuthorship W2039220450A5045714739 @default.
- W2039220450 hasAuthorship W2039220450A5050841050 @default.
- W2039220450 hasAuthorship W2039220450A5051867302 @default.
- W2039220450 hasAuthorship W2039220450A5058516635 @default.
- W2039220450 hasAuthorship W2039220450A5082018557 @default.
- W2039220450 hasAuthorship W2039220450A5082673485 @default.
- W2039220450 hasAuthorship W2039220450A5091068973 @default.
- W2039220450 hasBestOaLocation W20392204501 @default.
- W2039220450 hasConcept C146285616 @default.
- W2039220450 hasConcept C14858245 @default.
- W2039220450 hasConcept C153911025 @default.
- W2039220450 hasConcept C167734588 @default.